Dermata Therapeutics Inc (DRMA) Stock Analysis

Dermata Therapeutics Inc (DRMA) is a publicly traded company in the HEALTHCARE sector. It trades at $1.36, carries a market capitalization of $5.23M. This page summarizes the public market data, fundamentals, and frequently asked questions for DRMA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.36
• Market Cap: $5.23M
• EPS: $-4.17
• 52-Week High: $8.00
• 52-Week Low: $1.10

Market Sentiment

Dermata Therapeutics Inc currently has a Neutral sentiment score of 0.07.

About Dermata Therapeutics Inc

None

GNG Research Analysis

GNG Research scores Dermata Therapeutics Inc (DRMA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for DRMA.

Frequently Asked Questions

Does DRMA pay dividends?

Dermata Therapeutics Inc (DRMA) does not currently pay a regular dividend.

What is DRMA's market cap?

Dermata Therapeutics Inc (DRMA) has a market capitalization of $5.23M with a current stock price of $1.36.